Brazil
As a Brazilian with German heritage, I offer extensive expertise in the pharmaceutical industry, developed across local, regional, and global markets. In my current role as General Manager for Southern Cone, and having previously held roles such as Regional Commercial & Access Head for LATAM and other business leadership positions in Brazil, I have developed a broad expertise in both retail and non-retail (institutional) markets. My career journey has provided me with a comprehensive understanding of the pharma industry, with significant achievements in business development and market access. I excel in cultivating high-performing teams and have substantial experience in leading organizational transformation initiatives. Member of the Bayer Pharma Latin America leadership team and an executive member in the Chamber of Innovative Pharmaceutical Industries.
Dynamic and results-oriented Pharmaceutical Industry President with extensive experience leading operations across multiple countries in a collaborative cluster. Accountable for commercial P&L, including topline sales of ca. 150 mio. €, resource allocation within brands and countries, and leadership of ca. 150 employees. Management of critical areas of pharma governance including Marketing, Access & Commercial, Human Resources, Finance, Legal, Public & Government Affairs, Communications, Medical Affairs and Clinical Research, ensuring aligned strategies and operational excellence across all functions. Expert in strategic planning, market expansion, and implementing successful launches in both retail and non-retail (institutional) markets. Skilled in negotiating reimbursement strategies with payers to enhance product access. Adept at fostering a strong organizational culture and leading transformational projects that drive operational excellence and employee engagement. Strong leadership skills demonstrated through the successful management and development of high-performance teams, with a keen focus on execution and results. Capable of leading effectively in times of economic and political uncertainty, committed to navigating the complexities of the pharmaceutical landscape to achieve organizational goals.
Latin America Head of Strategic Marketing, Commercial and Market Access for Bayer Pharma. Member of the LatAm Leadership Team; reporting to Bayer Pharma Head of Latin America. Responsible for the regional portfolio and brand strategies, launch excellence, regional marketing & commercial, commercial excellence, market access & pricing across Latin American countries. Development of mid-long term organizational strategies, culture and change management. Coordination and leadership of brand communities across Latin American countries with a cross-functional marketing, medical, access, commercial excellence, regulatory and PS teams. Active member of global product teams, representing LatAm in global commercial forums, leading strategies and regional activation. Accountable for LatAm P&L, including topline sales of ca. 850 mio. € and resource allocation within brands and countries. ESG (Environmental, Social and Governance) champion for Bayer Pharma in Latin America, leading internal cross-functional teams and external stakeholders (payers, hospitals, patient associations, medical societies, government, etc) to foster sustainable efforts in improving human health through public access to medication in Latin America. Bayer Pharma transformational leader for Latin America, leading with passion this organizational change management in the countries. Indirect reports of the Marketing TA Heads; Commercial Heads; Commercial Excellence Heads; Market Access Heads in the Latin American countries/clusters.
Bayer Pharma Brazil Business Unit Head / Senior Director / VP Reporting to the Brazil General Manager & LatinAmerica President Cardiovascular brands: Xarelto & Aspirina Prevent & upcoming launches. Xarelto is the 1st product of the Brazilian Pharmaceutical Market (IQVIA - sales in value - 2020). Development of marketing strategies, retail & hospital sales force management, direct accountability over the business P&L (sales, costs/investments and margin/profitability). Accountable for over 115 mio Euro topline Sales. Direct leadership over 220 employees, including the internal marketing structure & external sales force teams (Hospital and Retail). Pharma sponsor for Innovation, Digital Transformation & LifeHub São Paulo at Bayer Brazil.
Multiple Esclerosis - Neurology : November 2003 to January 2004 Oncology : February 2004 to May 2004 Fertility Control (Gynecology): June 2004 to March 2007
Strategic Global office - Center of Dermatology in Berlin - Schering AG - Re-positioning of products - Global strategy of products